Science
Ask-the-expert: How vitamin D3-drug interactions can affect patient health
22 Jul 2021 | 3 min
Through our webinars and e-learning videos, we aim to provide up-to-date information on the role of vitamin active pharmaceutical ingredients and pharmaceutical lipids. Together with guest speakers, our experts deliver relevant discussions on today’s prominent medical concerns and highlight key scientific findings from the latest clinical trials.
Fast-evolving science on the beneficial role of vitamin D3 (cholecalciferol) for immune health is gaining increasing interest among the medical communities. The strong therapeutic potential of vitamin D3 is supported by a vast body of research. However, several drugs can interfere with vitamin D3 metabolism. This webinar discusses the consequences of vitamin D3 drug interactions, as well as how the administration of vitamin D3 can ameliorate the pharmacologic action of some drugs.
Optimizing nutrient intake is one way to support a better immune response and build a more resilient immune system for a longer term. Intake in optimal amounts is necessary to support the complex immune system and help reduce the risk, duration and severity of a virus infection. Building on latest consumer insights, market trends, and scientific evidence presented by leading experts, this webinar discusses innovation opportunities meeting future consumer appeal on the OTC shelf.
Failure to identify and properly manage DNIs can lead to severe consequences on patient outcomes. Increased understanding of prevalence and clinical relevance of DNIs is critical. This e-learning module introduces how DNIs are defined and classified, highlights which populations are most at risk, and emphasizes how the negative effects of DNIs can be minimized. Experts present relevant case studies, based on latest scientific evidence.
Presented by Prof. Catherine Field and Prof. Robert Chapkin, two of the world's leading experts in the molecular mechanisms by which lipids modulate cancer risk and therapy, the webinar will explore the current state of the science for EPA and DHA as a bioactive. Together with DSM's Dr. Keri Marshall, they will discuss the evidence for the use of lipids as a part of neoadjuvant therapy for two of the most common cancers: breast and colon.
22 Jul 2021 | 3 min
30 Jun 2021 | 4 min
26 May 2021 | 3 min
07 Apr 2021 | 4 min
17 Feb 2021 | 4 min
14 Dec 2020 | 4 min
29 Oct 2020 | 7 min
29 Sep 2020 | 7 min
02 Sep 2020 | 7 min
31 Jul 2020 | 8 min
18 Feb 2020 | 5 min
10 Oct 2018 | 4 min
01 May 2018 | 8 min
23 Apr 2018 | 7 min
26 Feb 2018 | 8 min
Request samples, place orders and view product documentation
Download the latest copy of our Solutions Catalogue
We’re more than a partner. We’re a competitive edge.
The latest in vitamin and lipid research and industry developments
Academic studies and the latest science in educational modules
Videos exploring the growing role of vitamin APIs and lipid API intermediates